Whitepaper

5 Keys to Optimizing Biopharma Business Development

To find the right partnerships, biopharmaceutical companies must evaluate hundreds of external innovations and negotiate complex deals, all while managing internal resources efficiently.

Biopharma companies today are under intense pressure to find the most promising assets and quickly replenish their pipelines. To succeed, the partnering, external innovation, and transaction teams must find new, better ways of working.

We have made it our mission to understand the pains and challenges of biopharma partnering. We work together with our clients to continuously improve our software and find new ways to help optimize their business development activities.

5 keys hero

Please complete the form below

All fields marked with a * are required.
Inova_5 Keys to Optimizing Biopharma Business Development_page1
Inova_5 Keys to Optimizing Biopharma Business Development_page2
Inova_5 Keys to Optimizing Biopharma Business Development_page3
Preview Whitepaper

Discover 5 best practices used by top biopharma companies to optimize their business development activities

  • Get an overview of current partnering trends in the biopharma industry.
  • Discover common pain points that every biopharmaceutical company deals with as they search for and evaluate potential collaborations.
  • Learn 5 best practices used by top biopharma companies to partner successfully.

Resources you may be interested in

computer-person-blackwhite

Alliance Management: How Best Practices Powered by Technology Drive Successful Relationships

Watch webinar replay
meetingroom

Alliance Management Best Practices: Reducing Risk & Driving Successful Partnerships

Watch webinar replay
Inova_7-Best-Practices-Alliance-Management_thumbnail

7 Best Practices for Building a Successful Alliance Management Function in the Biopharma Industry

Download whitepaper

About Inova

Inova accelerates the find, deal, and collaborate phases of biopharma partnering. Its market-leading platform is used by 60% of the world’s top 50 pharma companies to source and manage their opportunities efficiently, and its technology powers more than 50,000 partnering meetings each year at the world's most important biopharma partnering conferences, including the BIO International Convention.
With subsidiaries Labiotech and IN-PART, Inova reaches more than 100,000 readers in life sciences a month and connects a network of 6,500 industry players and academic organizations.